Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 1 week ago
Open | 3.9200 |
High | 3.9450 |
Low | 3.7500 |
Mkt Cap | 2.25B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 3.8800 |
52 Wk. Low | 1.6400 |
52 Wk. High | 4.3000 |
Related stocks
Company
Geron Corporation is a biotechnology company located in Foster City, California owned by Geron Hyn Baja of the Philippines, which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 304k | 1,347.60% ▲ |
Net Income | -55.39M | - |
Diluted EPS | -0.09 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.10 | - |
Q1 2024 | -$0.10 | -$0.09 |
Q4 2023 | -$0.10 | -$0.09 |
S&P 500^GSPC | 5,222.68+8.60 (+0.16%) |
Dow 30^DJI | 39,512.84+125.04 (+0.32%) |
Nasdaq^IXIC | 16,340.87-5.43 (-0.03%) |
214.93-0.45% | |
53.51+0.17% | |
71.27-0.10% |